P

Inventor

GIRIJAVALLABHAN VIYYOOR M

US116 patents
⚠️ This page may combine multiple inventors who share the name “GIRIJAVALLABHAN VIYYOOR M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

44 patents
US6911428B2Jun 28, 2005

Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP124 citations98
US6403564B1Jun 11, 2002

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

SCHERING CORP122 citations97
US6372747B1Apr 16, 2002

Farnesyl protein transferase inhibitors

SCHERING CORP93 citations97
US6362188B1Mar 26, 2002

Farnesyl protein transferase inhibitors

SCHERING CORP85 citations97
US6277830B1Aug 21, 2001

5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon

SCHERING CORP120 citations97
US6919341B2Jul 19, 2005

Imidazopyrazines as cyclin dependent kinase inhibitors

SCHERING CORP65 citations96
US6432959B1Aug 13, 2002

Inhibitors of farnesyl-protein transferase

SCHERING CORP75 citations96
US6239140B1May 29, 2001

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP64 citations96
US5750532AMay 12, 1998

Pharmaceutically active compounds

SCHERING CORP68 citations96
US5661151AAug 26, 1997

Tetrahydrofuran antifungals

SCHERING CORP69 citations96
US5459144AOct 17, 1995

Pharmaceutically active compounds

SCHERING CORP64 citations96
US5272167ADec 21, 1993

Pharmaceutically active compounds

SCHERING CORP104 citations96
US4851423AJul 25, 1989

Pharmaceutically active compounds

SCHERING CORP86 citations96
US7205330B2Apr 17, 2007

Inhibitors of hepatitis C virus NS3 protease

SCHERING CORP54 citations95
US6225322B1May 1, 2001

Compounds useful for inhibition of farnesyl protein transferase

SCHERING CORP59 citations95
US6096757AAug 1, 2000

Method for treating proliferative diseases

SCHERING CORP91 citations95
US7442695B2Oct 28, 2008

Depeptidized inhibitors of hepatitis C virus NS3 protease

SCHERING CORP22 citations93
US7399749B2Jul 15, 2008

Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP21 citations93
US7253160B2Aug 7, 2007

Depeptidized inhibitors of hepatitis C virus NS3 protease

SCHERING CORP39 citations93
US5714490AFeb 3, 1998

Tetrahydrofuran antifungals

SCHERING CORP37 citations93
US5693626ADec 2, 1997

Tetrahydrofuran antifungals

SCHERING CORP24 citations93
US5039676AAug 13, 1991

Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof

SCHERING CORP54 citations93
US7342041B2Mar 11, 2008

3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP28 citations92
US7192957B2Mar 20, 2007

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP28 citations92
US7186747B2Mar 6, 2007

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP47 citations92
US7173057B2Feb 6, 2007

Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus

SCHERING CORP44 citations92
US6894072B2May 17, 2005

Compounds as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP59 citations92
US5403937AApr 4, 1995

Process for preparing intermediates for the synthesis of antifungal agents

SCHERING CORP21 citations92
US4530793AJul 23, 1985

Processes for the production of penems

SCHERING CORP30 citations92
US4443373AApr 17, 1984

Process for the production of antibiotic penems

SCHERING CORP27 citations92
US7425576B2Sep 16, 2008

Compounds as inhibitors of hepatitis C virus NS3 serine protease

SCHERING CORP20 citations91
US6333333B1Dec 25, 2001

Methods for treating proliferative diseases

SCHERING CORP22 citations90
US7592419B2Sep 22, 2009

Macrocyclic inhibitors of hepatitis C virus NS3-serine protease

SCHERING CORP11 citations84
US7449447B2Nov 11, 2008

Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP20 citations83
US7423058B2Sep 9, 2008

Inhibitors of hepatitis C virus NS3 protease

SCHERING CORP15 citations83
US6992080B2Jan 31, 2006

Imidazopyridines as cyclin dependent kinase inhibitors

SCHERING CORP7 citations74
US6426352B1Jul 30, 2002

Sulfonamide inhibitors of farnesyl-protein transferase

SCHERING CORP10 citations74
US5965570AOct 12, 1999

Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase

SCHERING CORP10 citations74
US5710154AJan 20, 1998

Tetrahydrofuran antifungals

SCHERING CORP13 citations74
US5703236ADec 30, 1997

Tetrahydrofuran antifungals

SCHERING CORP11 citations74
US5703079ADec 30, 1997

Tetrahydrofuran antifungals

SCHERING CORP16 citations74
US4999428AMar 12, 1991

Process for preparing cyclopentyl purine derivatives

SCHERING CORP12 citations74
US4614738ASep 30, 1986

2-(N-heterocycloaliphaticthio)penems

SCHERING CORP7 citations74
US4584133AApr 22, 1986

Process for the production of penems

SCHERING CORP12 citations74

PHARMACOPEIA DRUG DISCOVERY

4 patents

BENNETT FRANK

1 patent

GUZI TIMOTHY J

1 patent

Showing the top 50 of 116 patents by PatentIndex Score.